| Term 
 
        | Medications that affect the heart and blood vessels as well as anticoagulant and antiplatelet agents that prevent clotting. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Uses for cardiac glycosides |  | Definition 
 
        | primarily in the treatment of heart failure |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Example of a cardiac Glycoside |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | process of establishing the correct therapeutic dose of digoxin for maintaing optimal functioning of the heart without toxic effects. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Include a variety of drugs that act in different ways to suppress various types of cardiac arrhythmias |  | 
        |  | 
        
        | Term 
 
        | Beta-Adrenergic Blockers (propranolol)
 |  | Definition 
 
        | prescribed for arrhythmias, hypertension and some forms of chronic angina. |  | 
        |  | 
        
        | Term 
 
        | Calcium Channel Blockers verapamil, diltiazem
 |  | Definition 
 
        | indicated for treatment of atrial fibrillation/flutter and PSVT. Also used in the treatment of angina and hypertension.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | systolic BP >140 diastolic BP > 90
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | systolic range of 120-139 diastolic range of 80-89
 |  | 
        |  | 
        
        | Term 
 
        | Lifestyle changes to avoid taking antihypertensive medications |  | Definition 
 
        | DASH diet reduce sodium intake
 increase physical activity
 modify alcohol use
 stop smoking
 |  | 
        |  | 
        
        | Term 
 
        | Most common side effect of antihypertensives |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Action of ACE Inhibitors enalapril, lisinopril, captopril
 |  | Definition 
 
        | lowers blood pressure by decreasing vasoconstriction |  | 
        |  | 
        
        | Term 
 
        | Action Angiotensin Receptor Blockers (ARBs) losartan, valsartan
 |  | Definition 
 
        | block the angiotensin receptor that causes vasoconstriction when stimulated by angiotensin II. |  | 
        |  | 
        
        | Term 
 
        | Uses for coronary vasodilators |  | Definition 
 
        | treatment of angina (angina pectoris)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Most commonly used for relief of acute angina pectoris |  | 
        |  | 
        
        | Term 
 
        | low-density lipoproteins (LDL) |  | Definition 
 
        | bad cholesterol; carry's the largest amount of the cholesterol in the blood and is responsible for transporting and depositing it in the arterial walls. |  | 
        |  | 
        
        | Term 
 
        | Very low-density lipoproteins (VLDL) |  | Definition 
 
        | triglycerides; precursors of LDL and compose the largest proportion of lipids in the diet, adipose tissue, and the blood |  | 
        |  | 
        
        | Term 
 
        | high-density lipoproteins (HDL) |  | Definition 
 
        | good cholesterol; help transport LDL cholesterol from the walls of the arteries through the bloodstream to the liver for excretion. |  | 
        |  | 
        
        | Term 
 
        | Statins atorvistatin, simvastatin
 |  | Definition 
 
        | most potent lipid-lowering medication available. First choice in managing high cholesterol. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | prevent formation of clots (embolism/thrombosis) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | alters the synthesis of blood coagulation factors in the liver by interfering with the action of vitamin K |  | 
        |  | 
        
        | Term 
 
        | laboratory method for monitoring therapy with coumarin derivatives |  | Definition 
 
        | International Normalized Ratio (INR) |  | 
        |  | 
        
        | Term 
 
        | Most common laboratory test for monitoring heparin therapy |  | Definition 
 
        | activated partial thromboplastin time (aPTT) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | prevent platelet clumping secondary prevention in patients with a history of recent stroke, recent MI, or established peripheral vascular disease.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Examples of platelet inhibitors |  | 
        |  |